BrightInsight just raised $40 million for its tech-savvy tools that help drugmakers get their treatments and devices over the finish line. It collects information from patients during clinical trials and from other care venues, then helps the final product get approved and used by everyday people. Business has been booming since coronavirus underscored the need for digital health, CEO and cofounder Dr. Kal Patel told Business Insider. Visit Business Insider's homepage for more stories.